Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
ImportanceThere is a high level of public and professional interest related to potential safety issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events were reported in phase 3 randomized controlled trials of their safety and efficacy. Moreover, none of the case series fro...
Main Authors: | Manan Pareek, Pasquale Sessa, Paolo Polverino, Francesco Sessa, Kristian Hay Kragholm, Maurizio Sessa |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Frontiers Media S.A.
2023-11-01
|
丛编: | Frontiers in Cardiovascular Medicine |
主题: | |
在线阅读: | https://www.frontiersin.org/articles/10.3389/fcvm.2023.1210007/full |
相似书籍
-
Disentangling a Thorny Issue: Myocarditis and Pericarditis Post COVID-19 and Following mRNA COVID-19 Vaccines
由: Concetta Rafaniello, et al.
出版: (2022-04-01) -
Risk of Myocarditis and Pericarditis among Young Adults following mRNA COVID-19 Vaccinations
由: Abdallah Alami, et al.
出版: (2022-05-01) -
Myocarditis and Pericarditis Following mRNA COVID-19 Vaccination: What Do We Know So Far?
由: Bibhuti B. Das, et al.
出版: (2021-07-01) -
Efficacy and Safety of AZD1222, BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2
由: Ilir Alimehmeti
出版: (2021-01-01) -
Humoral Immune Response in IBD Patients Three and Six Months after Vaccination with the SARS-CoV-2 mRNA Vaccines mRNA-1273 and BNT162b2
由: Richard Vollenberg, et al.
出版: (2022-01-01)